A reasonable approach includes: Baseline thyroid function tests (TSH and FT4) before starting GLP-1 therapy Repeat testing at 812 weeks after commencing treatment, particularly if significant weight loss occurs Further monitoring at 6 months , then annually if thyroid function remains stable Additional testing if symptoms of thyroid dysfunction develop After any levothyroxine dose change, NICE NG145 recommends re-checking thyroid function in 68 weeks to assess the adequacy of the adjustment
Ongoing research is also exploring the long-term benefits of weight loss injections, including improved metabolic health and reduced risk of obesity-related diseases
( 6 ) Factors that may influence recovery include your age and overall cardiovascular health, as well as the severity and length of your alcohol use, hormone levels including testosterone, and the presence of conditions like diabetes, obesity, or high blood pressure
(%) de hemoglobina glucosilada -Cambio estimado desde el inicio al final del tratamiento en SUSTAIN 1-7, monoterapia japonesa y combinacin de HGO* Japn estudios (semaglutida gris oscuro de 0.5 mg, semaglutida 1 mg negro, tratamiento competidores blanco y placebo gris claro
